A genome-wide scan reveals a maternal susceptibility locus for pre-eclampsia on chromosome 2p13

Hum Mol Genet. 1999 Sep;8(9):1799-805. doi: 10.1093/hmg/8.9.1799.

Abstract

Pre-eclampsia is a common and serious disease and a major cause of maternal and infant mortality. Antenatal care systems world-wide screen for signs of the disease such as hypertension and proteinuria. Unlike most other human disorders it impacts two individuals, the mother and the child, both of whom can be severely affected. The pathophysiology of the disorder is incompletely understood, but familial clustering of the disease is apparent. Here we report the results of a genome-wide screen of Icelandic families representing 343 affected women. Including those patients with non-proteinuric pre-eclampsia (gestational hypertension), proteinuric pre-eclampsia and eclampsia, we detected a significant locus on 2p13 with a lod score of 4.70 (single point P < 3.49 x 10(-6)). This is the first reported locus for pre-eclampsia meeting the criteria for genome-wide significance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chromosome Mapping
  • Chromosomes, Human, Pair 2*
  • Female
  • Genetic Linkage
  • Genetic Markers
  • Genetic Predisposition to Disease / genetics
  • Genome, Human
  • Genotype
  • Haplotypes
  • Humans
  • Iceland
  • Lod Score
  • Pedigree
  • Pre-Eclampsia / genetics*
  • Pregnancy

Substances

  • Genetic Markers